In this paper, we test the hypotheses that naturally occurring variations in the activity of the enzyme neutral sphingomyelinase-2 (NSM) may be a common origin of the clinically highly relevant co-morbidity trias of alcohol abuse, major depression and bone defects. The gene discussed is SMPD3; the disease is major depressive disorder.